P450 and NO Synthase Regulation by Multiprotein Complexes
多蛋白复合物对 P450 和 NO 合酶的调节
基本信息
- 批准号:10091457
- 负责人:
- 金额:$ 39.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApoproteinsArchitectureAryl Hydrocarbon HydroxylasesAwarenessBiologicalBiological AssayCYP2B4 geneCYP2E1 geneCell physiologyCellsClientComplexCryoelectron MicroscopyCytochrome P450DataDetergentsElectronsEnzymesFlavinsFunctional disorderFundingGrantGuanylate CyclaseHemeHemeproteinsHemoglobinImageImaging TechniquesKnowledgeLeadLengthLightLiverMediatingMembraneMembrane ProteinsMethodsMolecular ChaperonesMolecular ConformationMolecular Sieve ChromatographyMultiprotein ComplexesNADPH-Ferrihemoprotein ReductaseNatureNegative StainingNeuronsNitric Oxide SynthaseOxidation-ReductionOxygenasesPharmaceutical PreparationsPlayPolymersProcessProteinsQuality ControlRegulationResearchResolutionRoleSeaSteroid ReceptorsSteroidsStructureSystemTechniquesTimeUbiquitinationWorkbasechaperone machinerydimerheme ainterestlight scatteringmonomernovelparticleprotein complexrecruitstoichiometrysuccesssurfactanttoolubiquitin-protein ligase
项目摘要
ABSTRACT
We established that a multiprotein chaperone complex containing Hsp90/Hsp70 chaperones plays an essential
role in maintaining protein quality control of neuronal NO synthase (nNOS) and other P450 cytochromes. In the
last grant cycle, we turned our focus to determine the structure of nNOS by single particle EM and cryo-EM
methods to help elucidate what triggers chaperone recognition of nNOS. In the course of these studies, we
serendipitously discovered that full-length CYP2B4:cytochrome P450 reductase (CPR) complexes could form
in amphipols, which are surfactants that self-assemble and stabilize membrane proteins in the absence of
detergent. Remarkably, these complexes were fully functional, stable, and visible as tetramers by single
particle EM methods, and found to contain equimolar amounts of P450 and CPR. Thus, in the current
proposal, we aim to determine the first structure of a microsomal P450 in complex with CPR. Our prior
success in elucidating the first full-length dimeric structure of nNOS and P450 BM3 by these single particle
methods provides confidence in this undertaking. Currently we have resolved the structure of the oxygenase
domain of full-length nNOS to 5 Å resolution by cryo-EM methods. It is noteworthy that a tetrameric complex
of P450:CPR complex is analogous to the dimeric architecture of nNOS and BM3, both having a P450 and
CPR domain in each monomer. We have a collaborative team of EM experts whose knowledge will synergize
with our expertise in P450 and multi-protein complexes to tackle this exciting but challenging project. Also in
prior grant cycles, we showed that Hsp90 is needed for cellular heme insertion into heme-deficient apo-nNOS
and more recently the Stuehr lab has shown that Hsp90 is needed to insert heme into guanylate cyclase,
hemoglobin, and inducible NO synthase. Thus, premise exists for a chaperone complex that is a ‘heme
insertase’. Recently, we discovered that the cellular proteins that immunoprecipitate with apo-nNOS are stably
bound and catalyze heme insertion into apo-nNOS. Hsp90 and Hsp70 are bound to apo-nNOS and play a key
role in heme insertion but Hsp90 and Hsp70 chaperones alone are not sufficient. In the current proposal, we
seek to identify the other proteins that make up the heme insertase activity, in part by identification of
the co-immunoprecipitated proteins by LC-MS/MS. Moreover, we will define how the chaperone-based
heme insertase complex is assembled. The successful completion of the aims will provide a groundbreaking
new platform for the study of microsomal P450s, elucidate the first structure of a P450:CPR complex, and
characterize the protein machinery that inserts heme into hemeproteins.
摘要
我们确定了含有Hsp 90/Hsp 70分子伴侣的多蛋白分子伴侣复合物在Hsp 90/Hsp 70分子伴侣中起着重要的作用。
在维持神经元NO合酶(nNOS)和其他P450细胞色素的蛋白质质量控制中的作用。在
在上一个资助周期,我们将研究重点转向了用单粒子电镜和冷冻电镜来确定nNOS的结构
方法,以帮助阐明是什么触发分子伴侣识别nNOS。在这些研究中,我们
偶然发现,全长CYP 2B 4:细胞色素P450还原酶(CPR)复合物可以形成
在作为表面活性剂的两性分子中,其在不存在下自组装并稳定膜蛋白,
清洁剂。值得注意的是,这些复合物是完全功能性的,稳定的,并且通过单个聚合物可以看到四聚体。
颗粒EM方法,并发现含有等摩尔量的P450和CPR。因此,在目前
建议,我们的目标是确定与CPR复合的微粒体P450的第一个结构。我们事先
通过这些单颗粒成功阐明了nNOS和P450 BM 3的第一个全长二聚体结构
方法为这项工作提供了信心。目前,我们已经解决了加氧酶的结构
通过冷冻EM方法将全长nNOS的结构域分辨率提高到1.5 Å。值得注意的是,
P450:CPR复合物的二聚体结构类似于nNOS和BM 3的二聚体结构,两者都具有P450和
CPR结构域。我们有一个EM专家的协作团队,他们的知识将协同
凭借我们在P450和多蛋白质复合物方面的专业知识,我们可以解决这个令人兴奋但具有挑战性的项目。也
在之前的研究中,我们发现Hsp 90是血红素插入血红素缺陷型apo-nNOS所必需的
最近Stuehr实验室已经表明,Hsp 90是将血红素插入鸟苷酸环化酶所必需的,
血红蛋白和诱导型NO合酶。因此,前提存在的伴侣复合物是一个'血红素
插入酶。最近,我们发现与apo-nNOS免疫沉淀的细胞蛋白质是稳定的,
结合并催化血红素插入apo-nNOS。Hsp 90和Hsp 70与apo-nNOS结合,在apo-nNOS的表达中起关键作用
在血红素插入中的作用,但单独的Hsp 90和Hsp 70分子伴侣是不够的。在目前的提案中,我们
试图鉴定构成血红素插入酶活性的其他蛋白质,部分是通过鉴定
通过LC-MS/MS的免疫共沉淀蛋白。此外,我们将定义如何伴侣为基础的
装配血红素插入酶复合物。这些目标的成功完成将为我们提供一个
研究微粒体P450的新平台,阐明P450:CPR复合物的第一个结构,
表征将血红素插入血红素蛋白的蛋白质机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOICHI OSAWA其他文献
YOICHI OSAWA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOICHI OSAWA', 18)}}的其他基金
Drug-Mediated Alteration of Cytochrome P450
药物介导的细胞色素 P450 改变
- 批准号:
7917047 - 财政年份:2009
- 资助金额:
$ 39.57万 - 项目类别:
Inhibition and Inactivation of NO Synthase by Tobacco
烟草对 NO 合酶的抑制和灭活
- 批准号:
8033226 - 财政年份:2007
- 资助金额:
$ 39.57万 - 项目类别:
Inhibition and Inactivation of NO Synthase by Tobacco
烟草对 NO 合酶的抑制和灭活
- 批准号:
7416670 - 财政年份:2007
- 资助金额:
$ 39.57万 - 项目类别:
Inhibition and Inactivation of NO Synthase by Tobacco
烟草对 NO 合酶的抑制和灭活
- 批准号:
7796599 - 财政年份:2007
- 资助金额:
$ 39.57万 - 项目类别:
Inhibition and Inactivation of NO Synthase by Tobacco
烟草对 NO 合酶的抑制和灭活
- 批准号:
7577342 - 财政年份:2007
- 资助金额:
$ 39.57万 - 项目类别:
Inhibition and Inactivation of NO Synthase by Tobacco
烟草对 NO 合酶的抑制和灭活
- 批准号:
7183671 - 财政年份:2007
- 资助金额:
$ 39.57万 - 项目类别:
Drug-Mediated Alteration of Cytochrome P450
药物介导的细胞色素 P450 改变
- 批准号:
7225585 - 财政年份:2006
- 资助金额:
$ 39.57万 - 项目类别:
Chaperone recognition of xenobiotic-altered NO Synthase P450
异种生物改变的 NO 合酶 P450 的伴侣识别
- 批准号:
9060951 - 财政年份:2006
- 资助金额:
$ 39.57万 - 项目类别:
Drug-Mediated Alteration of Cytochrome P450
药物介导的细胞色素 P450 改变
- 批准号:
7619167 - 财政年份:2006
- 资助金额:
$ 39.57万 - 项目类别:
Drug-Mediated Alteration of Cytochrome P450
药物介导的细胞色素 P450 改变
- 批准号:
7889001 - 财政年份:2006
- 资助金额:
$ 39.57万 - 项目类别:
相似海外基金
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
8054533 - 财政年份:2011
- 资助金额:
$ 39.57万 - 项目类别:
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6930090 - 财政年份:2004
- 资助金额:
$ 39.57万 - 项目类别:
Analysis of the mechanisms for the recognition and the release of chromophores by chromoprotein apoproteins
色蛋白脱辅基蛋白识别和释放发色团的机制分析
- 批准号:
14380284 - 财政年份:2002
- 资助金额:
$ 39.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6609132 - 财政年份:2002
- 资助金额:
$ 39.57万 - 项目类别:
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6501904 - 财政年份:2001
- 资助金额:
$ 39.57万 - 项目类别:
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6324727 - 财政年份:2000
- 资助金额:
$ 39.57万 - 项目类别:
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6199965 - 财政年份:1999
- 资助金额:
$ 39.57万 - 项目类别:
STRUCTURE AND FUNCTION OF SURFACTANT APOPROTEINS
表面活性剂脱蛋白的结构和功能
- 批准号:
6109550 - 财政年份:1998
- 资助金额:
$ 39.57万 - 项目类别:
TUBERCULOSIS, HIV AND SURFACTANT APOPROTEINS
结核病、艾滋病毒和表面活性剂脱辅基蛋白
- 批准号:
6056556 - 财政年份:1998
- 资助金额:
$ 39.57万 - 项目类别:
TUBERCULOSIS, HIV AND SURFACTANT APOPROTEINS
结核病、艾滋病毒和表面活性剂脱辅基蛋白
- 批准号:
6527336 - 财政年份:1998
- 资助金额:
$ 39.57万 - 项目类别: